Artiva BiotherapeuticsARTV
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 40 institutions reported holding Artiva Biotherapeutics Inc. (ARTV) in their 13F filings, down 8 from Q2 2025. 6 opened new positions and 14 sold out. The largest holders were Ra Capital Management, L.P. ($28.3M), 5AM Venture Management, LLC ($6.8M) and Venrock Adviser, LLC ($4.6M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Artiva Biotherapeutics Inc.
- CUSIP
- 04317A107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $519K |
| Exits | 14 | $1.3M |
All 13F filers, Q2 2025 → Q3 2025: 1,088,048 shares bought and 1,443,041 shares sold, net −354,993 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| Ra Capital Management, L.P. | 0.35% | No change | 9,853,302 | $28.3M |
| 5AM Venture Management, LLC | 2.47% | No change | 2,353,304 | $6.8M |
| Venrock Adviser, LLC | 0.26% | No change | 1,609,569 | $4.6M |
| venBio Partners LLC | 1.87% | No change | 1,148,975 | $3.3M |
| Citadel Advisors | 0.00% | Add +419.3% | 798,397 | $2.3M |
| Franklin Resources Inc. | 0.00% | No change | 520,327 | $1.5M |
| BlackRock, Inc. | 0.00% | Reduce -39.4% | 294,422 | $845K |
| Millennium Management | 0.00% | Reduce -19.9% | 262,160 | $752K |
| Wellington Management Group LLP | 0.00% | No change | 194,108 | $557K |
| Vanguard Group Inc. | 0.00% | Reduce -31.7% | 159,118 | $457K |
| BNP Paribas Financial Markets | 0.00% | Add +14463.5% | 118,547 | $340K |
| Geode Capital Management, LLC | 0.00% | Reduce -30.3% | 110,896 | $319K |
| Citigroup Inc. | 0.00% | Add +2859.7% | 105,573 | $303K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 100,000 | $287K |
| Renaissance Technologies | 0.00% | New | 79,147 | $227K |
| State Street Corp. | 0.00% | Reduce -4.8% | 59,824 | $172K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -57.8% | 49,777 | $143K |
| XTX Topco Ltd | 0.01% | New | 47,973 | $138K |
| Morgan Stanley | 0.00% | Reduce -7.4% | 42,829 | $123K |
| Landscape Capital Management, L.L.C. | 0.01% | New | 39,133 | $112K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 35,000 | $100K |
| HRT Financial LP | 0.00% | Reduce -65.3% | 26,953 | $77K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -34.0% | 25,552 | $73K |
| UBS Group AG | 0.00% | Add +533.6% | 21,143 | $61K |
| Two Sigma Investments, LP | 0.00% | Reduce -4.7% | 20,364 | $58K |
| Bank of America Corp. | 0.00% | Add +225.8% | 16,145 | $46K |
| Prelude Capital Management, LLC | 0.00% | New | 14,302 | $41K |
| Barclays PLC | 0.00% | Add +566.1% | 12,696 | $36K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.2% | 9,981 | $29K |
| Russell Investments Group, Ltd. | 0.00% | No change | 5,491 | $16K |
| FMR LLC | 0.00% | Reduce -88.4% | 4,920 | $14K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -12.5% | 4,281 | $12K |
| JPMorgan Chase & Co. | 0.00% | Add +362.7% | 4,002 | $11K |
| Wells Fargo & Company | 0.00% | Reduce -17.6% | 1,700 | $5K |
| Royal Bank of Canada | 0.00% | Reduce -25.0% | 840 | $3K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +0.3% | 944 | $3K |
| GF Fund Management Co. LTD. | 0.00% | Reduce -15.4% | 510 | $1K |
| Mark Sheptoff Financial Planning, LLC | 0.00% | No change | 400 | $1K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 159 | $456 |
| Cloud Capital Management, LLC | 0.00% | New | 11 | $0 |
"% of holder's portfolio" is ARTV's weight in each manager's 13F, not the share of Artiva Biotherapeutics Inc. the manager owns.